CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Adverse drug reactions - Management
Which kind of suspected adverse drug reactions should I report?
- Consider reporting all serious and previously unreported suspected adverse drug reactions using the Yellow Card scheme:
- Report suspected adverse reactions of these kinds to any therapeutic agent, including prescribed medicines, over-the-counter and self-administered medicines, blood products, vaccines, radiographic contrast media and herbal products.
- Report any suspected adverse reactions involving Black Triangle drugs.
- If in doubt, it is best to submit a report.
- When reporting an adverse drug reaction, it is not necessary to be certain that an adverse drug reaction (ADR) has occurred in order to submit a Yellow Card report.
- For more information, see Additional information.
© NHS Institute for Innovation and Improvement